Insider filing · ACAD
James M Daly
Director
profile →
ACADIA Pharmaceuticals Inc.
ACAD · Healthcare · 12 filings in 24 months
ticker →
James M Daly sold $671K of ACADIA Pharmaceuticals (ACAD)
Executed Nov 10 2025, disclosed Nov 12 2025, 2 days later.
Value, as filed
$671K
30,000 sh × $22.37
Executed
Nov 10 2025
the trade date, as filed
Disclosed
Nov 12 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JDJames M Daly (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in ACADIA Pharmaceuticals Inc. (ACAD). The largest single filing was $671K of ACAD (30,000 sh × $22.37, as filed), executed Nov 10 2025.
The name
ACADHealthcare · ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for neurological an…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→